BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23287644)

  • 1. 3p14.1 de novo microdeletion involving the FOXP1 gene in an adult patient with autism, severe speech delay and deficit of motor coordination.
    Palumbo O; D'Agruma L; Minenna AF; Palumbo P; Stallone R; Palladino T; Zelante L; Carella M
    Gene; 2013 Mar; 516(1):107-13. PubMed ID: 23287644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable phenotype in 17q12 microdeletions: clinical and molecular characterization of a new case.
    Palumbo P; Antona V; Palumbo O; Piccione M; Nardello R; Fontana A; Carella M; Corsello G
    Gene; 2014 Apr; 538(2):373-8. PubMed ID: 24487052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH.
    Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E
    Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
    Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
    J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo 0.57 Mb microdeletion in chromosome 11q13.1 in a patient with speech problems, autistic traits, dysmorphic features and multiple endocrine neoplasia type 1.
    Mohrmann I; Gillessen-Kaesbach G; Siebert R; Caliebe A; Hellenbroich Y
    Eur J Med Genet; 2011; 54(4):e461-4. PubMed ID: 21600320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiari I malformation, delayed gross motor skills, severe speech delay, and epileptiform discharges in a child with FOXP1 haploinsufficiency.
    Carr CW; Moreno-De-Luca D; Parker C; Zimmerman HH; Ledbetter N; Martin CL; Dobyns WB; Abdul-Rahman OA
    Eur J Hum Genet; 2010 Nov; 18(11):1216-20. PubMed ID: 20571508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WNT2 gene polymorphism associated with speech delay inherent to autism.
    Lin PI; Chien YL; Wu YY; Chen CH; Gau SS; Huang YS; Liu SK; Tsai WC; Chiu YN
    Res Dev Disabil; 2012; 33(5):1533-40. PubMed ID: 22522212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 785kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosis.
    Pariani MJ; Spencer A; Graham JM; Rimoin DL
    Eur J Med Genet; 2009; 52(2-3):123-7. PubMed ID: 19332160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
    Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
    J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP1 mutations cause intellectual disability and a recognizable phenotype.
    Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF
    Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency of CMIP in a girl with autism spectrum disorder and developmental delay due to a de novo deletion on chromosome 16q23.2.
    Van der Aa N; Vandeweyer G; Reyniers E; Kenis S; Dom L; Mortier G; Rooms L; Kooy RF
    Autism Res; 2012 Aug; 5(4):277-81. PubMed ID: 22689534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
    Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
    Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.
    Fernandez BA; Roberts W; Chung B; Weksberg R; Meyn S; Szatmari P; Joseph-George AM; Mackay S; Whitten K; Noble B; Vardy C; Crosbie V; Luscombe S; Tucker E; Turner L; Marshall CR; Scherer SW
    J Med Genet; 2010 Mar; 47(3):195-203. PubMed ID: 19755429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment.
    Marseglia G; Scordo MR; Pescucci C; Nannetti G; Biagini E; Scandurra V; Gerundino F; Magi A; Benelli M; Torricelli F
    Eur J Med Genet; 2012 Mar; 55(3):216-21. PubMed ID: 22333924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism-associated familial microdeletion of Xp11.22.
    Qiao Y; Liu X; Harvard C; Hildebrand MJ; Rajcan-Separovic E; Holden JJ; Lewis ME
    Clin Genet; 2008 Aug; 74(2):134-44. PubMed ID: 18498374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.